Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Free Access

Practical Suitability of a Stand-Alone Oscillometric Central Blood Pressure Monitor: A Review of the Microlife WatchBP Office Central

Verberk W.J.a, b · Cheng H.c-e · Huang L.-C.b · Lin C.-M.b · Teng Y.-P.b · Chen C.-H.c-e

Author affiliations

aCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands; bDepartment of Research and Development, Microlife Corporation, cDepartment of Medical Education, Taipei Veterans General Hospital, and Departments of dMedicine and ePublic Health, National Yang-Ming University, Taipei, Taiwan, ROC

Corresponding Author

Willem J. Verberk

Microlife Corp.

9F, No. 431, RuiGuang Rd.

Taipei 114, Taiwan (ROC)

E-Mail Willem.verberk@microlife.ch

Related Articles for ""

Pulse 2015;3:205-216

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

Accumulating evidence indicates that central blood pressure (CBP) is a better cardiovascular risk predictor than brachial blood pressure (BP). Although more additional benefits of CBP-based treatment above usual hypertension treatment are to be demonstrated, the demand for implementing CBP assessment in general clinical practice is increasing. For this, the measurement procedure must be noninvasive, easy to perform, and cost- and time-efficient. Therefore, oscillometric devices with the possibility to assess CBP seem the best option. Recently, such an oscillometric BP monitor, the Microlife WatchBP Office Central, was developed, which demonstrated its high accuracy in a validation study against invasive BP measurement. Calibration errors of this device are limited because the procedure is automated, standardized, and performed at the same place of and within 30 s from pulse wave assessment. The transformation from the peripheral pulse wave to CBP is done by means of an individual-based pulse wave analysis according to a theory of arterial compliance and wave reflections. In addition, the device has demonstrated to enable a more reliable diagnosis of hypertension by CBP than by peripheral BP, with a lower frequency of over- and underdiagnosis. Altogether, the available clinical evidence suggests that the Microlife WatchBP Office Central fulfills the criteria for general clinical use.

© 2016 S. Karger AG, Basel


References

  1. Murray WB, Gorven AM: Invasive vs non-invasive blood pressure measurements - the influence of the pressure contour. S Afr Med J 1991;79:134-139.
    External Resources
  2. Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH: Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 2011;29:454-459.
  3. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007;50:197-203.
  4. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB, Masotti G, Roman MJ: Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008;51:2432-2439.
  5. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM: Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002;39:735-738.
  6. Sharman J, Stowasser M, Fassett R, Marwick T, Franklin S: Central blood pressure measurement may improve risk stratification. J Hum Hypertens 2008;22:838-844.
  7. Boutouyrie P, Achouba A, Trunet P, Laurent S: Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension 2010;55:1314-1322.
  8. Morgan T, Lauri J, Bertram D, Anderson A: Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004;17:118-123.
  9. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213-1225.
  10. Protogerou AD, Papaioannou TG, Lekakis JP, Blacher J, Safar ME: The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. I. (Patho)-physiology, rationale and perspective on pulse pressure amplification. Curr Pharm Des 2009;15:267-271.
  11. Miyashita H: Clinical assessment of central blood pressure. Curr Hypertens Rev 2012;8:80-90.
  12. Picone DS, Climie RED, Ahuja KDK, Keske MA, Sharman JE: Brachial-to-radial SBP amplification: implications of age and estimated central blood pressure from radial tonometry. J Hypertens 2015;33:1876-1883.
  13. Climie RE, Picone DS, Keske MA, Sharman JE: Brachial-to-radial systolic blood pressure amplification in patients with type 2 diabetes mellitus. J Hum Hypertens 2015, Epub ahead of print.
  14. Shih YT, Cheng HM, Sung SH, Chuang SY, Hu WC, Chen CH: Is noninvasive brachial systolic blood pressure an accurate estimate of central aortic systolic blood pressure? Am J Hypertens 2015, Epub ahead of print.
  15. Millasseau S, Agnoletti D: Non-invasive estimation of aortic blood pressures: a close look at current devices and methods. Curr Pharm Des 2015;21:709-718.
  16. Stergiou GS, Lin CW, Lin CM, Chang SL, Protogerou AD, Tzamouranis D, Nasothimiou E, Tan TM: Automated device that complies with current guidelines for office blood pressure measurement: design and pilot application study of the Microlife WatchBP Office device. Blood Press Monit 2008;13:231-235.
  17. Saladini F, Benetti E, Masiero S, Palatini P: Accuracy of Microlife WatchBP Office ABI monitor assessed according to the 2002 European Society of Hypertension protocol and the British Hypertension Society protocol. Blood Press Monit 2011;16:258-261.
  18. Sung SH, Cheng HM, Chuang SY, Shih YT, Wang KL, Chen YH, Lin SJ, Yu WC, Chen CH: Measurement of central systolic blood pressure by pulse volume plethysmography with a noninvasive blood pressure monitor. Am J Hypertens 2012;25:542-548.
  19. Cheng HM, Wang KL, Chen YH, Lin SJ, Chen LC, Sung SH, Ding PY, Yu WC, Chen JW, Chen CH: Estimation of central systolic blood pressure using an oscillometric blood pressure monitor. Hypertens Res 2010;33:592-599.
  20. Cheng HM, Sung SH, Shih YT, Chuang SY, Yu WC, Chen CH: Measurement accuracy of a stand-alone oscillometric central blood pressure monitor: a validation report for Microlife WatchBP Office Central. Am J Hypertens 2013;26:42-50.
  21. Alpert BS, Quinn DE, Friedman BA: A review of the latest guidelines for NIBP device validation. Blood Press Monit 2013;18:297-302.
  22. Association for the Advancement of Medical Instrumentation: American National Standard: Electronic or Automated Sphygmomanometers. Arlington, Association for the Advancement of Medical Instrumentation, 2009.
  23. Liu Z, Brin KP, Yin FC: Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol 1986;251:H588-H600.
    External Resources
  24. Lin MM, Cheng HM, Sung SH, Liao CF, Chen YH, Huang PH, Chen CH: Estimation of central aortic systolic pressure from the second systolic peak of the peripheral upper limb pulse depends on central aortic pressure waveform morphology. J Hypertens 2012;30:581-586.
  25. Cheng HM, Sung SH, Shih YT, Chuang SY, Yu WC, Chen CH: Measurement of central aortic pulse pressure: noninvasive brachial cuff-based estimation by a transfer function vs. a novel pulse wave analysis method. Am J Hypertens 2012;25:1162-1169.
  26. Shih YT, Cheng HM, Sung SH, Hu WC, Chen CH: Quantification of the calibration error in the transfer function-derived central aortic blood pressures. Am J Hypertens 2011;24:1312-1317.
  27. Davies JI, Band MM, Pringle S, Ogston S, Struthers AD: Peripheral blood pressure measurement is as good as applanation tonometry at predicting ascending aortic blood pressure. J Hypertens 2003;21:571-576.
  28. Cloud GC, Rajkumar C, Kooner J, Cooke J, Bulpitt CJ: Estimation of central aortic pressure by SphygmoCor requires intra-arterial peripheral pressures. Clin Sci (Lond) 2003;105:219-225.
  29. Hunyor SN, Flynn JM, Cochineas C: Comparison of performance of various sphygmomanometers with intra-arterial blood-pressure readings. BMJ 1978;2:159-162.
  30. Holland WW, Humerfelt S: Measurement of blood-pressure: comparison of intra-arterial and cuff values. BMJ 1964;2:1241-1243.
  31. O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, Imai Y, Wang J, Mengden T, Shennan A; Working Group on Blood Pressure Monitoring of the European Society of Hypertension: European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010;15:23-38.
  32. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altman DG, Bland M, Coats A, Atkins N: An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993;11:677-679.
    External Resources
  33. Ribezzo S, Spina E, Di Bartolomeo S, Sanson G: Noninvasive techniques for blood pressure measurement are not a reliable alternative to direct measurement: a randomized crossover trial in ICU. ScientificWorldJournal 2014;2014:353628.
  34. Dasnadi S, Aliaga S, Laughon M, Warner DD, Price WA: Factors influencing the accuracy of noninvasive blood pressure measurements in NICU infants. Am J Perinatol 2015;32:639-644.
  35. Wax DB, Lin HM, Leibowitz AB: Invasive and concomitant noninvasive intraoperative blood pressure monitoring: observed differences in measurements and associated therapeutic interventions. Anesthesiology 2011;115:973-978.
  36. VanBeck JO, White RD, Abenstein JP, Mullany CJ, Orszulak TA: Comparison of axillary artery or brachial artery pressure with aortic pressure after cardiopulmonary bypass using a long radial artery catheter. J Cardiothorac Vasc Anesth 1993;7:312-315.
  37. McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB: Central blood pressure: current evidence and clinical importance. Eur Heart J 2014;35:1719-1725.
  38. Bazaral MG, Welch M, Golding LA, Badhwar K: Comparison of brachial and radial arterial pressure monitoring in patients undergoing coronary artery bypass surgery. Anesthesiology 1990;73:38-45.
    External Resources
  39. Li W-y, Wang X-h, Lu L-c, Li H: Discrepancy of blood pressure between the brachial artery and radial artery. World J Emerg Med 2013;4:294-297.
    External Resources
  40. Schultz MG, Davies JE, Hardikar A, Pitt S, Moraldo M, Dhutia N, Hughes AD, Sharman JE: Aortic reservoir pressure corresponds to cyclic changes in aortic volume physiological validation in humans. Arterioscler Thromb Vasc Biol 2014;34:1597-1603.
  41. Hametner B, Wassertheurer S, Hughes AD, Parker KH, Weber T, Eber B: Reservoir and excess pressures predict cardiovascular events in high-risk patients. Int J Cardiol 2014;171:31-36.
  42. Davies JE, Lacy P, Tillin T, Collier D, Cruickshank JK, Francis DP, Malaweera A, Mayet J, Stanton A, Williams B, Parker KH, Thom SAM, Hughes AD: Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes Trial. Hypertension 2014;64:60-68.
  43. Verbeke F, Segers P, Heireman S, Vanholder R, Verdonck P, Van Bortel LM: Noninvasive assessment of local pulse pressure: importance of brachial-to-radial pressure amplification. Hypertension 2005;46:244-248.
  44. Mitchell GF: Central pressure should not be used in clinical practice. Artery Res 2015;9:8-13.
  45. Laugesen E, Rossen NB, Peters CD, Maeng M, Ebbehoj E, Knudsen ST, Hansen KW, Botker HE, Poulsen PL: Assessment of central blood pressure in patients with type 2 diabetes: a comparison between SphygmoCor and invasively measured values. Am J Hypertens 2014;27:169-176.
  46. Soender TK, Van Bortel LM, Moller JE, Lambrechtsen J, Hangaard J, Egstrup K: Impact of calibration on estimates of central blood pressures. J Hum Hypertens 2012;26:706-710.
  47. Wassertheurer S, Baumann M: Assessment of systolic aortic pressure and its association to all cause mortality critically depends on waveform calibration. J Hypertens 2015;33:1884-1889.
  48. Protogerou AD, Argyris AA, Papaioannou TG, Kollias GE, Konstantonis GD, Nasothimiou E, Achimastos A, Blacher J, Safar ME, Sfikakis PP: Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study. J Hypertens 2014;32:1805-1814.
  49. Shih YT, Cheng HM, Sung SH, Hu WC, Chen CH: Comparison of two generalized transfer functions for measuring central systolic blood pressure by an oscillometric blood pressure monitor. J Hum Hypertens 2013;27:204-210.
  50. Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF: Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? Stroke 2000;31:463-468.
  51. Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P, Battista F, Settimi L, Desamericq G, Dolbeau G, Faini A, Salvi P, Mannarino E, Parati G: Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012;60:369-377.
  52. Amoore JN, Lemesre Y, Murray IC, Mieke S, King ST, Smith FE, Murray A: Automatic blood pressure measurement: the oscillometric waveform shape is a potential contributor to differences between oscillometric and auscultatory pressure measurements. J Hypertens 2008;26:35-43.
  53. Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R: Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension. Vasc Health Risk Manag 2011;7:709-717.
  54. Takahashi H, Yoshika M, Yokoi T: Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010. Vasc Health Risk Manag 2013;9:265-272.
  55. Rezai MR, Goudot G, Winters C, Finn JD, Wu FC, Cruickshank JK: Calibration mode influences central blood pressure differences between SphygmoCor and two newer devices, the Arteriograph and Omron HEM-9000. Hypertens Res 2011;34:1046-1051.
  56. Segers P, Mahieu D, Rietzschel ER, De Buyzere ML, Van Bortel LM: Impact of radial artery pressure waveform calibration on estimated central pressure using a transfer function approach. Hypertension 2008;52:e24-e25; author reply e26.
  57. Papaioannou TG, Protogerou A, Stefanadis C: Comparison between Mobil-O-Graph and the SphygmoCor device for central systolic blood pressure estimation: consensus is required for ‘validation protocols'. Blood Press Monit 2012;17:259-260; author reply 260-261.
  58. Lehmann ED: Cited ‘validation' references for the SphygmoCor device. Kidney Int 2001;59:1597-1598.
  59. O'Rourke MF, Pauca A, Jiang XJ: Pulse wave analysis. Br J Clin Pharmacol 2001;51:507-522.
  60. Borlaug BA, Olson TP, Mohamed SA, Melenovsky V, Sorrell VL, Noonan K, Lin G, Redfield MM: A randomized pilot study of aortic waveform guided therapy in chronic heart failure. J Am Heart Assoc 2014;3:e000745.
  61. Sharman JE, Marwick TH, Gilroy D, Otahal P, Abhayaratna WP, Stowasser M; Value of Central Blood Pressure for GUIDing ManagEment of Hypertension Study Investigators: Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care principal findings of the BP GUIDE Study. Hypertension 2013;62:1138-1145.
  62. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators: Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity - The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753-1760.
  63. Cheng HM, Chuang SY, Sung SH, Yu WC, Pearson A, Lakatta EG, Pan WH, Chen CH: Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. J Am Coll Cardiol 2013;62:1780-1787.
  64. Cheng HM, Sung SH, Chuang SY, Pearson A, Tufanaru C, White S, Yu WC, Chen CH: Diagnostic performance of a stand-alone central blood pressure monitor: application of central blood pressure in the diagnosis of high blood pressure. Am J Hypertens 2014;27:382-391.
  65. Cheng HM, Pearson A, Sung SH, Yu WC, Chen CH, Karnon J: Cost-effectiveness of noninvasive central blood pressure monitoring in the diagnosis of hypertension. Am J Hypertens 2015;28:604-614.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: February 12, 2016
Issue release date: April 2016

Number of Print Pages: 12
Number of Figures: 2
Number of Tables: 1

ISSN: 2235-8676 (Print)
eISSN: 2235-8668 (Online)

For additional information: https://www.karger.com/PLS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.